Safety and Efficacy of Myeloablative Conditioning Autologous Stem Cell Transplantation, Targeted Immunotherapy, and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Children, Adolescents, and Young Adults with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

Authors

Aliza Gardenswartz, New York Medical College
Brinda Mehta
Nader K. El-Mallawany, New York Medical CollegeFollow
Carmella van de Ven, New York Medical CollegeFollow
Jessica Hochberg, New York Medical CollegeFollow
Allyson Flower, New York Medical CollegeFollow
Erin Morris
Lauren Harrison
Jaclyn Basso
Perry Gerard, New York Medical College
Janet Ayello, New York Medical CollegeFollow
Lee Ann Baxter-Lowe
Mitchell S. Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

3-2019

Journal Title

Biology of Blood and Marrow Transplantation

Department

Pediatrics

Second Department

Radiology

Recommended Citation

Gardenswartz, A., Mehta, B., El-Mallawany, N. K., van de Ven, C., Hochberg, J., Flower, A., Morris, E., Harrison, L., Basso, J., Gerard, P., Ayello, J., Baxter-Lowe, L., & Cairo, M. S. (2019). Safety and Efficacy of Myeloablative Conditioning Autologous Stem Cell Transplantation, Targeted Immunotherapy, and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Children, Adolescents, and Young Adults with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation, 25 (3 Suppl.1), S412. https://doi.org/https://doi.org/10.1016/j.bbmt.2018.12.832